Zobrazeno 1 - 10
of 15
pro vyhledávání: '"J R, Leclerc"'
Autor:
A. P. Reiner, S. M. Schwartz, M. B. Frank, W.T. Longstreth, L. A. Hindorff, G. Teramura, F. R. Rosendaal, L. K. Gaur, B. M. Psaty, D. S. Siscovick, J. R. Leclerc
Publikováno v:
Stroke. 32:2580-2587
Background and Purpose — Although family studies have suggested a genetic influence on hemorrhagic stroke, the underlying genetic risk factors remain poorly defined. Coagulation factor XIII, which is involved in hemostasis, fibrinolysis, vascular r
Autor:
S Haviernick, J. R. Leclerc, Shannon Atkinson, J. Bourgouin, W. H. Geerts, F Laroche, Louis Desjardins, F. Jobin, F. Delorme
Publikováno v:
Thrombosis and Haemostasis. 67:417-423
SummaryConsecutive patients undergoing knee arthroplasty or tibial osteotomy at four participating hospitals received either enoxaparin, 30 mg subcutaneously every 12 h (n = 66) or an identicalappearing placebo (n = 65). All study medications started
Autor:
J R, Leclerc
Publikováno v:
Stroke. 32(11)
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 103:597-599
Publikováno v:
Thrombosis and haemostasis. 81(3)
Symptoms and clinical signs individually are inaccurate for the diagnosis of DVT. However, when assessing patients with leg symptoms, clinicians have access to additional information, such as whether or not DVT risk factors are present that could imp
Publikováno v:
Chest. 114(2 Suppl)
Publikováno v:
Archives of internal medicine. 158(8)
Despite low molecular weight heparin prophylaxis, the incidence of venographically detected, residual deep vein thrombosis after hip and knee arthroplasty remains high, at approximately 15% and 30%, respectively. Most of these thrombi are asymptomati
Publikováno v:
Journal (Canadian Dental Association). 62(5)
The World Health Organization (WHO), the International Committee for Thrombosis and Hemostasis, and the International Committee for Standardization in Hematology, have strongly suggested that INR (International Normalized Ratio) values should be used
Autor:
J R, Leclerc, W H, Geerts, L, Desjardins, F, Jobin, F, Laroche, F, Delorme, S, Haviernick, S, Atkinson, J, Bourgouin
Publikováno v:
Thrombosis and haemostasis. 67(4)
Consecutive patients undergoing knee arthroplasty or tibial osteotomy at four participating hospitals received either enoxaparin, 30 mg subcutaneously every 12 h (n = 66) or an identical-appearing placebo (n = 65). All study medications started the m
Autor:
J. R. Leclerc
Publikováno v:
Archives of Internal Medicine. 145:1867-1869